Favorable outcome of amphotericin B treatment of zygomycotic necrotizing fascitis caused by Apophysomyces elegans.
Devi
Sheela C
SC
Department of Clinical Microbiology, Pondicherry Institute of Medical Sciences, Pondicherry, India. sheeladevic@yahoo.com
Kanungo
Reba
R
Barreto
Elvino
E
Thomas
Abraham G
AG
Shashikala
Nair
N
Srinivasan
S
S
Anitha
Patricia K
PK
D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D003646:Debridement; D019115:Fasciitis, Necrotizing / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009090:Mucorales / Q000254:growth & development / Q000302:isolation & purification*; D009091:Mucormycosis / Q000188:drug therapy* / Q000601:surgery; D016038:Skin Transplantation; D014946:Wound Infection
D000935:Antifungal Agents; D000666:Amphotericin B